Extended pharmacological profiles of rat P2Y 2 and rat P2Y 4 receptors and their sensitivity to extracellular H + and Zn 2+ ions

British Journal of Pharmacology

Volumn 140, Issue 7, 2003, Pages 1177-1186

  Wildman, Scott S ^a   Unwin, Robert J ^a   King, Brian F ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

Extracellular pH; GPCR; Oocyte; P2U receptor; P2Y receptor; P2Y 2 receptor; P2Y 4 receptor; Purinoceptor; Zinc

Indexed keywords

2 AMINO 4 PHOSPHONOBUTYRIC ACID; ADENOSINE TRIPHOSPHATE DERIVATIVE; HYDROCHLORIC ACID; PURINE P2Y2 RECEPTOR; PURINE P2Y4 RECEPTOR; PYRIDOXAL PHOSPHATE 6 AZOPHENYL 2',4' DISULFONIC ACID; RECEPTOR SUBTYPE; SURAMIN; URIDINE TRIPHOSPHATE; ZINC CHLORIDE;

ACIDIFICATION; AGONIST; ANIMAL CELL; ARTICLE; COMPETITIVE INHIBITION; CONTROLLED STUDY; DRUG POTENCY; INTERCELLULAR SPACE; INTERMETHOD COMPARISON; NONHUMAN; PH MEASUREMENT; PRIORITY JOURNAL; RECEPTOR INTRINSIC ACTIVITY; RECEPTOR SENSITIVITY; XENOPUS;

ADENOSINE TRIPHOSPHATE; ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HYDROGEN-ION CONCENTRATION; KINETICS; MEMBRANE POTENTIALS; OOCYTES; PATCH-CLAMP TECHNIQUES; PROTONS; RATS; RECEPTORS, PURINERGIC P2; SURAMIN; URIDINE TRIPHOSPHATE; XENOPUS; ZINC;

EID: 1642463459     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0705544     Document Type: Article

References (43)

1. 14 receptor) adds diversity to the P2Y receptor family. Trends Pharmacol. Sci., 24, 52-55.
2. BARNARD, E.A., BURNSTOCK, G. & WEBB, T.E. (1994). G protein-coupled receptors for ATP and other nucleotides: a new receptor family. Trends Pharmacol. Sci., 15, 67-70.
3. 4 nucleotide receptor. Br. J. Pharmacol., 124, 428-430.
4. BROOKS, S.P. & STOREY, K.B. (1992). Bound and determined: a computer program for making buffers of defined ion concentrations. Anal. Biochem., 201, 119-126.
5. 4 receptors: characterization of a suramin and PPADS-insensitive response to UTP. Br. J. Pharmacol., 119, 1301-1303.
6. 2 purinoceptor by zinc and pH. J. Physiol. (Lond.), 539, 347-359.
7. 2 purinoceptor. J. Neurosci., 22, 3873-3880.
8. COMMUNI, D., PIROTTON, S., PARMENTIER, M. & BOEYNAEMS, J.M. (1995). Cloning and functional expression of a human uridine nucleotide receptor. J. Biol. Chem., 270, 30849-30852.
9. 11 receptor. Br. J. Pharmacol., 128, 1199-1206.
10. DAINTY, I.A., POLLARD, C.E., ROBERTS, S.M., FRANKLIN, M., MCKECHNIE, K.C.W. & LEFF, P. (1994). Evidence for subdivision of P2U-purinoceptors based on suramin sensitivity. Br. J. Pharmacol., 112, 578P.
11. DUBYAK, G.R. (1991). Signal transduction by P2-purinergic receptors for extracellular ATP. Am. J. Respir. Cell. Mol. Biol., 4, 295-300.
12. DUBYAK, G.R. & El-MOATASSIM, C. (1993). Signal transduction via P2-purinergic receptors for extracellular ATP and other nucleotides. Am. J. Physiol., 265, C577-606.
13. ERB, L., LUSTIG, K.D., SULLIVAN, D.M., TURNER, J.T. & WEISMAN, G.A. (1993). Functional expression and photoaffinity labeling of a cloned P2U purinergic receptor. Proc. Nat. Acad. Sci. U.S.A., 90, 10449-10453.
14. ERB, L., GARRAD, R., WANG, Y., QUINN, T., TURNER, J.T. & WEISMAN, G.A. (1995). Sited-directed mutagenesis of P2U purinoceptors. Positively charged amino acids in transmembrane helices 6 and 7 affect agonist potency and specificity. J. Biol. Chem., 270, 4185-4188.
15. 4 receptor to neuronal ion channels. Br. J. Pharmacol., 138, 400-406.
16. FREISSMUTH, M., WALDHOER, M., BOFILL-CARDONA, E. & NANOFF, C. (1999). G protein antagonists. Trends Pharmacol. Sci., 20, 237-245.
17. HILEY, C.R., BOTTRILL, F.E., WARNOCK, J. & RICHARDSON, P.J. (1995). Effects of pH on responses to adenosine, CGS 21680, carbachol and nitroprusside in the isolated perfused superior mesenteric arterial bed of the rat. Br. J. Pharmacol., 116, 2641-2646.
18. HOYLE, C.H.V., HILDERMAN, R.H., PINTOR, J.J., SCHLUTER, H. & KING, B.F. (2001). Diadenosine polyphosphates as extracellular signal molecules. Drug Devel. Res., 52, 260-273.
19. KENAKIN, T. (2002). Drug efficacy at G protein-coupled receptors. Ann. Rev. Pharmacol. Toxicol., 42, 349-379.
20. 4 receptor. Mol. Pharmacol., 57, 926-931.
21. KING, B.F., TOWNSEND-NICHOLSON, A. & BURNSTOCK, G. (1998). Metabotropic receptors for ATP and UTP: exploring the correspondence between native and recombinant nucleotide receptors. Trends Pharmacol. Sci., 19, 506-514.
22. KING, B.F., WANG, S. & BURNSTOCK, G. (1996a). P2 purinoceptor- activated inward currents in follicular oocytes of Xenopus laevis. J. Physiol. (Lond.), 494, 17-28.
23. 2 purinoceptor to ATP revealed by changing extracellular pH. Br. J. Pharmacol., 117, 1371-1373.
24. LAZAROWSKI, E.R., ROCHELLE, L.G., O'NEAL, W.K., RIBEIRO, C.M., GRUBB, B.R., ZHANG, V., HARDEN, T.K. & BOUCHER, R.C. (2001). Cloning and functional characterization of two murine uridine nucleotide receptors reveal a potential target for correcting ion transport deficiency in cystic fibrosis gallbladder. J. Pharmacol. Exp. Ther., 297, 43-49.
25. LUSTIG, K.D., SHIAU, A.K., BRAKE, A. & JULIUS, D. (1993). Expression cloning of an ATP receptor from mouse neuroblastoma cells. Proc. Nat. Acad. Sci. U.S.A., 90, 5113-5117.
26. LUSTIG, K.D., SPORTIELLO, M.G., ERB, L. & WEISMAN, G.A. (1992). A nucleotide receptor in vascular endothelial cells is specifically activated by the fully ionized forms of ATP and UTP. Biochem. J., 284, 733-739.
27. 2B adenosine receptors in NG108-15 cells. Biochem. Pharmacol., 55, 595-603.
28. NGUYEN, T., ERB, L., WEISMAN, G.A., MARCHESE, A., HENG, H.H., GARRAD, R.C., GEORGE, S.R., TURNER, J.T. & O'DOWD, B.F. (1995). Cloning, expression, and chromosomal localization of the human uridine nucleotide receptor gene. J. Biol. Chem., 270, 30845-30848.
29. O'CONNOR, S.E., DAINTY, I.A. & LEFF, P. (1991). Further subclassification of ATP receptors based on agonist studies. Trends Pharmacol. Sci., 12, 137-141.
30. PARR, C.E., SULLIVAN, D.M., PARADISO, A.M., LAZAROWSKI, E.R., BURCH, L.H., OLSEN, J.C., ERB, L., WEISMAN, G.A., BOUCHER, R.C. & TURNER, J.T. (1994). Cloning and expression of a human P2U nucleotide receptor, a target for cystic fibrosis pharmacotherapy. Proc. Nat. Acad. Sci. U.S.A., 91, 3275-3279.
31. PENDERGAST, W., YERXA, B.R., DOUGLASS-III, J.G., SHAVER, S.R., Dougherty, R.W., REDICK, C.C., SIMS, I.F. & RIDEOUT, J.L. (2001). Synthesis and P2Y receptor activity of a series of uridine dinucleoside 5′-polyphosphates. Bioorg. Med. Chem. Lett., 11, 157-160.
32. PINTOR, J., KING, B.F., ZIGANSHIN, A.U., MIRAS-PORTUGAL, M.T. & BURNSTOCK, G. (1996). Diadenosine polyphosphate-activated inward and outward currents in follicular oocytes of Xenopus laevis. Life Sci., 59, 179-184.
33. RALEVIC, V. & BURNSTOCK, G. (1998). Receptors for purines and pyrimidines. Pharmacol. Rev., 50, 413-492.
34. 2 purinoceptor in intimal lesions of the rat aorta. Arterioscler. Thromb. Vasc. Biol., 17, 3602-3610.
35. SMART, T.G., XIE, X. & KRISHEK, B.J. (1994). Modulation of inhibitory and excitatory amino acid receptor ion channels by zinc. Prog. Neuroblol., 42, 393-441.
36. 4 nucleotide receptor. Eur. J. Pharmacol., 416, 197-202.
37. 11 receptor in stably transfected haematological cell lines. Mol. Cell. Biochem., 213, 75-81.
38. 1 receptors and of platelet aggregation. Biochem. Biophys. Res. Commun., 256, 94-97.
39. VON KÜGELGEN, I., HAUSSINGER, D. & STARKE, K. (1987). Evidence for a vasoconstriction-mediating receptor for UTP, distinct from the P2 purinoceptor, in rabbit ear artery. Naunyn Schmiedeberg's Arch. Pharmacol., 336, 556-560.
40. 4 receptor. J. Neurochem., 71, 1348-1357.
41. 2 receptors and its dependence on extracellular pH. Br. J. Pharmacol., 123, 1214-1220.
42. 4 abundance in rat kidney epithelial cysts and its properties in vitro. J. Am. Soc. Nephrol., 13, F-P0272 (abstract).
43. 2 receptor of MDCK cells: cloning, expression, and cell-specific signalling. Am. J. Physiol., 219, 1049-1052.